Trial Profile
AML08: A Phase III Randomized Trial of Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Phase II Study Of Natural Killer Cell Transplantation In Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jan 2024
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine; Daunorubicin; Etoposide
- Indications Acute myeloid leukaemia
- Focus Registrational; Therapeutic Use
- 12 Dec 2023 Results evaluating interactions between outcomes by race and cytarabine pharmacogenomics in pediatric AML patients, presented at the 65th American Society of Hematology Annual Meeting and Exposition
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 10 Sep 2020 Status changed from active, no longer recruiting to completed.